HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Fadrozole

A selective aromatase inhibitor effective in the treatment of estrogen-dependent disease including breast cancer.
Also Known As:
CGS-16949A; Fadrozole Hydrochloride; Fadrozole Monohydrochloride; CGS 16949A; CGS16949A; Hydrochloride, Fadrozole; Monohydrochloride, Fadrozole; Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-
Networked: 84 relevant articles (13 outcomes, 26 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Ohashi, Y: 2 articles (01/2003 - 10/2000)
2. Tominaga, T: 2 articles (01/2003 - 10/2000)
3. Harvey, Harold A: 2 articles (08/2002 - 03/2002)
4. Lipton, Allan: 2 articles (08/2002 - 03/2002)
5. Fukuda, K: 2 articles (11/2001 - 08/2000)
6. Yamamoto, M: 2 articles (11/2001 - 08/2000)
7. Kitano, H: 2 articles (11/2001 - 08/2000)
8. Taniguchi, H: 2 articles (11/2001 - 08/2000)
9. Kokufu, I: 2 articles (11/2001 - 08/2000)
10. Yano, T: 2 articles (11/2001 - 08/2000)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Neoplasms (Cancer)
3. Neoplasm Metastasis (Metastasis)
4. Endometriosis (Adenomyosis)
5. Nausea

Related Drugs and Biologics

1. Aromatase (CYP19)
2. letrozole (Femara)
3. Tamoxifen
4. anastrozole (Arimidex)
5. formestane
6. exemestane (Aromasin)
7. Cyclophosphamide (Cytoxan)
8. Aromatase Inhibitors
9. Megestrol Acetate (Borea)
10. Aminoglutethimide (Cytadren)

Related Therapies and Procedures

1. Ovariectomy (Oophorectomy)
2. Injections
3. Intra-Arterial Infusions
4. Drug Therapy (Chemotherapy)
5. Oral Administration